APN News

  • Friday, October, 2021| Today's Market | Current Time: 09:33:48
  • BIOTRONIK Cardiac Device Donation Helps 75 Impoverished Heart Patients in Trinidad and Tobago

    Germany: BIOTRONIK SE Co. & KG, a leading manufacturer of implantable cardiac devices, has provided a donation of implantable cardiac defibrillators (ICD) and pacemaker device implants to more than 75 low-income and impoverished patients in the Republic of Trinidad & Tobago as part of its collaboration with Heartbeat International Foundation Inc. (HBI). Globally, one to […]

    WHO highlights action on antibiotic use on the occasion of ‘Health Day’

    The World Health Organisation has warned that drug resistance fueled partly by a misuse of antibiotics is killing hundreds of thousands of people a year and that urgent action was needed on the issue. “We’re really seeing an accelerated evolution in the spread of this problem and the bottomline is that the problem is outpacing […]

    CSR and Growth must go Hand in Hand for Inclusive Growth: K D Singh, Chairman, Alchemist Group

    New Delhi : Mr K D Singh, Rajya Sabha MP, and the man behind the 10000 crore Alchemist Group says that now the time has come for corporates to not only focus on just profits but do so with a much more bigger focus on corporate social responsibility. Commenting on the renewed debate on Corporate […]

    BIOTRONIK Announces Positive 6-month Results for Pantera Lux Paclitaxel Releasing Balloon

    United States: Six-month results from the PEPPER (Paclitaxel REleasing Balloon in Patients PresEnting with In-Stent Restenosis) study demonstrating a very low number of revascularizations and no cardiac deaths were presented on Sunday at the American College of Cardiology (ACC) conference by Professor Christoph Hehrlein, MD, University Medical Center, Freiburg, Germany and clinical coordinating investigator of […]

    Breakthrough therapy dabigatran provides consistent benefit across all atrial fibrillation types and stroke risk groups

    Germany: New data from two RE-LY® sub-group analyses has presented at the 60th Annual Scientific Session of the American College of Cardiology (ACC) demonstrated that dabigatran etexilate 150mg bid is consistently superior to warfarin in stroke prevention in atrial fibrillation (AF), irrespective of a patient’s risk of stroke or type of AF.1,2 RE-LY®, the largest […]

    UpToDate Provides Free Access to Its Medical Content to All Users in Japan

    United States : UpToDate, a part of Wolters Kluwer Health, has announced that it is providing free access to its online medical content to all users in Japan. This decision was made by the company immediately following the recent earthquake and tsunami that devastated the country’s northeast coast. In addition, individuals and organizations worldwide now […]

    Boehringer Ingelheim’s lead hepatitis C compound moves into Phase III – the first within the BI HCV portfolio

    Germany: Boehringer Ingelheim has announced the study outline for the pivotal Phase III clinical trials designed to evaluate BI 201335, its investigational once-daily oral protease inhibitor, in both treatment-naïve and -experienced patients with chronic genotype-1 hepatitis C virus (HCV), the most challenging genotype to treat. In parallel, the U.S. Food and Drug Administration (FDA) has […]

    NeuroLogica Corporation Announces FDA 510(k) Clearance for BodyTomT: A Portable, Full Body, Multi-Slice CT Scanner

    United States: NeuroLogica Corporation announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the world’s first portable, full body, multi-slice CT scanner, the BodyTom™. (www.NeuroLogica.com) The BodyTom™ is the newest offering in NeuroLogica’s portable computed tomography imaging line. BodyTom™ is a completely portable, full body, 32 slice CT that […]

    CIGNA Enters Global Individual Health Market; Launches CIGNA Global Health Options

    United States : CIGNA ,the global leader in serving expatriates and other globally mobile individuals, has launched an international health care plan for qualified individuals who seek access to high-quality health care facilities across international boundaries. The individual consumer market is a new area of focus for CIGNA’s expatriate benefits operation. With CIGNA Global Health […]

    Erbitux Indication Extension Submitted for 1st-Line Advanced or Metastatic NSCLC in the EU

    Germany: Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that it has submitted an indication extension to the European Medicines Agency (EMA) for the approval of Erbitux® (cetuximab) in combination with standard 1st line platinum-based chemotherapy in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with high epidermal growth factor […]